Doctors Organic Chemicals Profile
Key Indicators
- Authorised Capital ₹ 37.00 Cr
- Paid Up Capital ₹ 4.71 Cr
- Company Age 38 Year, 9 Months
- Open Charges ₹ 52.77 Cr
- Satisfied Charges ₹ 9.07 Cr
About Doctors Organic Chemicals
Company Details
- Location
Godavari, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230AP1986PLC006446
- Company No.
006446
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 May 1986
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Doctors Organic Chemicals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashokkumar Shinkar  | Director | 04-May-2005 | Current |
| Chandran Krishnamoorthy | Director | 04-May-2005 | Current |
| Koduru Moorthy | Director | 04-May-2005 | Current |
Financial Performance of Doctors Organic Chemicals.
Enhance accessibility to Doctors Organic Chemicals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Doctors Organic Chemicals?
Unlock access to Doctors Organic Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Wanbury LimitedChandran Krishnamoorthy is a mutual person
Asenka Homes LlpAshokkumar Shinkar is a mutual person
- Strugence Capital Advisors Llp
Ashokkumar Shinkar is a mutual person
- Strugence Pharma And Healthcare Investme Nt Advisors Llp
Ashokkumar Shinkar is a mutual person
- Strugence Investment Advisors Llp
Ashokkumar Shinkar is a mutual person
- Strugence Sustainable Ventures Llp
Ashokkumar Shinkar is a mutual person
Charges (Loans)
₹52.77 Cr
₹9.07 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 30.00 Cr
- Uti Bank Ltd : 14.80 Cr
- I.D.B.I. Bank Ltd. : 5.00 Cr
- Industrial Development Bank Of India : 2.50 Cr
- Andhra Bank : 0.47 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jul 2006 | State Bank Of India | ₹30.00 Cr | Open |
| 26 Apr 2006 | Uti Bank Ltd | ₹14.80 Cr | Open |
| 19 Jun 1996 | Industrial Development Bank Of India | ₹2.50 Cr | Open |
| 05 Aug 1993 | I.D.B.I. Bank Ltd. | ₹5.00 Cr | Open |
| 25 Nov 1992 | Andhra Bank | ₹4.69 M | Open |
How Many Employees Work at Doctors Organic Chemicals?
Unlock and access historical data on people associated with Doctors Organic Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Doctors Organic Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Doctors Organic Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.